China Non-Invasive Prenatal Testing Market Eases Early Detection of Rare Diseases

Mar 29,2022 | Healthcare Services

Technological advancements in the field of life sciences and healthcare industry have helped us to tackle with numerous health complications. One such innovation introduced by medical science is Non-invasive prenatal testing (NIPT). This modernized method is a form of prenatal screening that detects genetic conditions or abnormalities of foetuses by using the pregnant woman’s blood samples. Since majority of rare diseases are genetic in nature, NIPT has been adopted by many countries and regions to determine risks during pregnancy. 

China Non–Invasive Prenatal Testing (NIPT) Market size is anticipated to reach US$ 825 million by 2028, registering a CAGR of 6.4% over the forecast period. According to this new market research report offered by Bharatbook, the analysis presents a comprehensive study of the entire China non-invasive prenatal testing market.

The report covers the most up–to–date industry data on the actual market situation and future outlook for the China non-invasive prenatal testing market. The study also provides up–to–date historical market size data for the period 2018 – 2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in China.

Furthermore, the report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, NIPT test volume, revenues and provides forecasts through 2028. The report also includes an assessment of comparative test analysis by companies.

It also covers reimbursement patterns and offers a clear view of the regulatory landscape in the China non–invasive prenatal testing market. Key trends in terms of collaboration deals, partnerships, mergers & acquisitions, venture capital investment, distribution, and licensing agreements are analysed in detail. The report also explores the detailed description of market drivers and inhibitors of the China non–invasive prenatal testing market.

The report concludes with the profiles of major players in the China non–invasive prenatal testing market. The key market players are evaluated on various parameters such as business overview, product outlook and key development in the non–invasive prenatal testing market in China. The leading companies for the China Non–Invasive Prenatal Testing Market include Basetra, Berry Genomics and BGI Diagnosis Co. Ltd.

For more information, please visit China Non–Invasive Prenatal Testing (NIPT) market